Portfolio of Renaissance Technologies
Renaissance Technologies was founded by Jim Simons († 2024) and makes investment decisions with mathematical models; the portfolio holds a very large number of stocks.
Source: 13F filing with the US Securities and Exchange Commission dated May 14, 2020. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q1 2020. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 103.0B USD
- Positions
- 3,401
- Share of the ten largest
- 15.1%
The ten largest positions Q1 2020
- Bristol Myers Squibb 3.6%▲ +9.6%
- Novo Nordisk (ADR) 1.6%▲ +6.3%
- Vertex Pharmaceuticals 1.6%▼ −3.1%
- Verisign 1.4%▼ −2.0%
- Biogen 1.4%▼ −2.1%
- Allergan PLC 1.2%▲ +41.2%
- Chipotle Mexican Grill 1.2%▲ +4.3%
- Walmart 1.1%▲ +9.8%
- Humana 1.1%▲ +19.6%
- AbbVie 1.0%▲ +14.9%
Show all positions of this quarter
Choose a quarter (54 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
- Q1 2014
- Q4 2013
- Q3 2013
- Q2 2013
All positions Q1 2020
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| NVO Novo Nordisk (ADR) | 1.6% | 27,860,226 | 1.7B USD | +6.3% increased | Q2 2013 or earlier 28 quarters |
| VRSN Verisign | 1.4% | 8,105,290 | 1.5B USD | −2.0% reduced | Q2 2013 or earlier 28 quarters |
| Glaxosmithkline PLC | 0.8% | 23,076,454 | 874.4M USD | +21.3% increased | Q2 2013 or earlier 28 quarters |
| AMGN Amgen | 0.7% | 3,750,003 | 760.2M USD | +18.7% increased | Q2 2013 or earlier 28 quarters |
| HSY Hershey Company (The) | 0.7% | 5,255,138 | 696.3M USD | +17.0% increased | Q2 2013 or earlier 28 quarters |
| DPZ Domino's | 0.6% | 1,981,525 | 642.2M USD | +16.1% increased | Q2 2013 or earlier 28 quarters |
| Molina Healthcare Inc | 0.6% | 4,148,109 | 579.5M USD | −0.6% reduced | Q2 2013 or earlier 28 quarters |
| ALGN Align Technology | 0.5% | 2,938,229 | 511.1M USD | +12.5% increased | Q2 2013 or earlier 28 quarters |
| CL Colgate-Palmolive | 0.5% | 7,023,996 | 466.1M USD | +50.3% increased | Q2 2013 or earlier 28 quarters |
| AEE Ameren | 0.4% | 5,463,157 | 397.9M USD | +19.5% increased | Q2 2013 or earlier 28 quarters |
| Cboe Global Markets Inc | 0.4% | 4,399,653 | 392.7M USD | −3.5% reduced | Q2 2013 or earlier 28 quarters |
| United Therapeutics Corp Del | 0.3% | 3,590,223 | 340.4M USD | +1.3% increased | Q2 2013 or earlier 28 quarters |
| Icon PLC | 0.3% | 2,501,319 | 340.2M USD | +6.6% increased | Q2 2013 or earlier 28 quarters |
| Cogent Communications HLDGS | 0.3% | 3,567,366 | 292.4M USD | −0.6% reduced | Q2 2013 or earlier 28 quarters |
| CLX Clorox | 0.2% | 1,477,580 | 256.0M USD | +72.6% increased | Q2 2013 or earlier 28 quarters |
| Kinross Gold Corp | 0.2% | 63,101,071 | 251.1M USD | +2.7% increased | Q2 2013 or earlier 28 quarters |
| Haemonetics Corp | 0.2% | 2,184,385 | 217.7M USD | −10.5% reduced | Q2 2013 or earlier 28 quarters |
| Markel Corp | 0.2% | 210,571 | 195.4M USD | −2.6% reduced | Q2 2013 or earlier 28 quarters |
| New York Times Co | 0.2% | 5,668,686 | 174.1M USD | +0.4% increased | Q2 2013 or earlier 28 quarters |
| CRL Charles River Laboratories | 0.2% | 1,337,388 | 168.8M USD | −6.3% reduced | Q2 2013 or earlier 28 quarters |
| Rogers Communications Inc | 0.1% | 3,491,383 | 145.0M USD | +2.9% increased | Q2 2013 or earlier 28 quarters |
| Bank Nova Scotia B C | 0.1% | 3,429,900 | 139.3M USD | −27.6% reduced | Q2 2013 or earlier 28 quarters |
| Telus Corporation | 0.1% | 8,572,800 | 135.3M USD | – | Q2 2013 or earlier 28 quarters |
| PEP PepsiCo | 0.1% | 1,083,004 | 130.1M USD | −2.4% reduced | Q2 2013 or earlier 28 quarters |
| Pnm Res Inc | 0.1% | 3,379,100 | 128.4M USD | +25.9% increased | Q2 2013 or earlier 28 quarters |
| Chunghwa Telecom Co Ltd | 0.1% | 3,429,571 | 122.0M USD | +5.0% increased | Q2 2013 or earlier 28 quarters |
| ECHO EchoStar | 0.1% | 3,703,401 | 118.4M USD | −5.3% reduced | Q2 2013 or earlier 28 quarters |
| National Beverage Corp | 0.1% | 2,647,296 | 112.9M USD | −1.5% reduced | Q2 2013 or earlier 28 quarters |
| Cosan Ltd | 0.1% | 8,978,442 | 110.4M USD | −0.3% reduced | Q2 2013 or earlier 28 quarters |
| Dolby Laboratories Inc | 0.1% | 2,024,757 | 109.8M USD | −4.2% reduced | Q2 2013 or earlier 28 quarters |
| Pan Amern Silver Corp | 0.1% | 7,592,904 | 108.8M USD | +19.7% increased | Q2 2013 or earlier 28 quarters |
| Bce Inc | 0.1% | 2,568,789 | 105.0M USD | +13.9% increased | Q2 2013 or earlier 28 quarters |
| Aspen Technology Inc | 0.1% | 1,101,803 | 104.7M USD | −43.9% reduced | Q2 2013 or earlier 28 quarters |
| Gold Fields Ltd New | < 0.1% | 20,477,400 | 97.3M USD | −12.9% reduced | Q2 2013 or earlier 28 quarters |
| Tfs Finl Corp | < 0.1% | 6,330,622 | 96.7M USD | −0.4% reduced | Q2 2013 or earlier 28 quarters |
| Vector Group Ltd | < 0.1% | 10,226,037 | 96.3M USD | +1.3% increased | Q2 2013 or earlier 28 quarters |
| Capitol Fed Finl Inc | < 0.1% | 8,205,495 | 95.3M USD | −0.4% reduced | Q2 2013 or earlier 28 quarters |
| Csg Sys Intl Inc | < 0.1% | 2,244,356 | 93.9M USD | −0.9% reduced | Q2 2013 or earlier 28 quarters |
| Rayonier Inc | < 0.1% | 3,950,509 | 93.0M USD | −4.9% reduced | Q2 2013 or earlier 28 quarters |
| Usana Health Sciences Inc | < 0.1% | 1,581,700 | 91.4M USD | −2.7% reduced | Q2 2013 or earlier 28 quarters |
| Lancaster Colony Corp | < 0.1% | 628,263 | 90.9M USD | +8.1% increased | Q2 2013 or earlier 28 quarters |
| Commvault Systems Inc | < 0.1% | 2,230,687 | 90.3M USD | −10.9% reduced | Q2 2013 or earlier 28 quarters |
| AWK American Water Works | < 0.1% | 746,700 | 89.3M USD | +354.2% increased | Q2 2013 or earlier 28 quarters |
| IDXX Idexx Laboratories | < 0.1% | 351,125 | 85.1M USD | −45.1% reduced | Q2 2013 or earlier 28 quarters |
| Heico Corp New | < 0.1% | 1,316,200 | 84.1M USD | −19.5% reduced | Q2 2013 or earlier 28 quarters |
| Morningstar Inc | < 0.1% | 717,570 | 83.4M USD | +5.0% increased | Q2 2013 or earlier 28 quarters |
| Shenandoah Telecommunication | < 0.1% | 1,661,700 | 81.8M USD | +6.1% increased | Q2 2013 or earlier 28 quarters |
| Ecopetrol S A | < 0.1% | 8,464,786 | 80.5M USD | +8.2% increased | Q2 2013 or earlier 28 quarters |
| Potlatchdeltic Corporation | < 0.1% | 2,542,313 | 79.8M USD | −1.7% reduced | Q2 2013 or earlier 28 quarters |
| WD-40 Co | < 0.1% | 362,423 | 72.8M USD | +0.4% increased | Q2 2013 or earlier 28 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Show more (up to 500) Shown: the 50 longest-held of 3,401 positions.
Breakdown by sector
- Health Care 13.8%
- Consumer Staples 6.4%
- Technology 6.3%
- Utilities 5.7%
- Consumer Discretionary 4.1%
- Financials 2.2%
- Communication Services 2.1%
- Real Estate 2.0%
- Industrials 1.5%
- Materials 0.8%
- Energy 0.5%
- not in our coverage 54.7%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors